4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Ischemic Heart Diseases
Ischemic heart diseases often referred to as coronary artery disease, occur when blood flow to the heart is reduced due to narrowed or blocked coronary arteries. This restriction, usually caused by atherosclerosis, deprives the heart muscle of oxygen and nutrients, leading to symptoms like chest pain (angina), fatigue, and shortness of breath. Severe or prolonged ischemia can result in a heart attack, posing life-threatening risks. Managing ischemic heart diseases involves lifestyle changes, medications to improve blood flow, and medical interventions like stenting or bypass surgery. Early diagnosis and treatment play a vital role in preventing complications and improving long-term cardiac health. With ongoing advancements in cardiology, innovative therapies are offering patients new opportunities for recovery and improved quality of life.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom